Quantifying the inflammatory secretome of human intermuscular adipose tissue

Adipose tissue secretes an abundance of lipid and protein mediators, and this secretome is depot‐specific, with local and systemic effects on metabolic regulation. Intermuscular adipose tissue (IMAT) accumulates within the skeletal muscle compartment in obesity, and is associated with insulin resistance and metabolic disease. While the human IMAT secretome decreases insulin sensitivity in vitro, its composition is entirely unknown. The current study was conducted to investigate the composition of the human IMAT secretome, compared to that of the subcutaneous (SAT) and visceral adipose tissue (VAT) depots. IMAT, SAT, and VAT explants from individuals with obesity were used to generate conditioned media. Proteomics analysis of conditioned media was performed using multiplex proximity extension assays, and eicosanoid analysis using liquid chromatography–tandem mass spectrometry. Compared to SAT and/or VAT, IMAT secreted significantly more cytokines (IL2, IL5, IL10, IL13, IL27, FGF23, IFNγ and CSF1) and chemokines (MCP1, IL8, CCL11, CCL20, CCL25 and CCL27). Adipokines hepatocyte growth factor and resistin were secreted significantly more by IMAT than SAT or VAT. IMAT secreted significantly more eicosanoids (PGE2, TXB2, 5‐HETE, and 12‐HETE) compared to SAT and/or VAT. In the context of obesity, IMAT is a distinct adipose tissue with a highly immunogenic and inflammatory secretome, and given its proximity to skeletal muscle, may be critical to glucose regulation and insulin resistance.

[1]  H. Rakugi,et al.  Interleukin‐15 receptor subunit alpha regulates interleukin‐15 localization and protein expression in skeletal muscle cells , 2022, Experimental physiology.

[2]  Jingli Lu,et al.  Adipose Tissue-Resident Immune Cells in Obesity and Type 2 Diabetes , 2019, Front. Immunol..

[3]  Tzulip Phang,et al.  Intermuscular adipose tissue directly modulates skeletal muscle insulin sensitivity in humans. , 2019, American journal of physiology. Endocrinology and metabolism.

[4]  K. Avin,et al.  Fibroblast growth factor 23 does not directly influence skeletal muscle cell proliferation and differentiation or ex vivo muscle contractility. , 2018, American journal of physiology. Endocrinology and metabolism.

[5]  S. Hohmann,et al.  The G2A Receptor Controls Polarization of Macrophage by Determining Their Localization Within the Inflamed Tissue , 2018, Front. Immunol..

[6]  P. Proost,et al.  Chemokine-Induced Macrophage Polarization in Inflammatory Conditions , 2018, Front. Immunol..

[7]  M. Mingler,et al.  Eosinophils support adipocyte maturation and promote glucose tolerance in obesity , 2018, Scientific Reports.

[8]  G. Escobedo,et al.  Serum Levels of Interleukin-13 Increase in Subjects with Insulin Resistance but Do Not Correlate with Markers of Low-Grade Systemic Inflammation , 2018, Journal of diabetes research.

[9]  Marnie L. Gruen,et al.  Elevating adipose eosinophils in obese mice to physiologically normal levels does not rescue metabolic impairments , 2017, Molecular metabolism.

[10]  J. Fenton,et al.  Obesity is positively associated with arachidonic acid-derived 5- and 11-hydroxyeicosatetraenoic acid (HETE). , 2017, Metabolism: clinical and experimental.

[11]  M. Akash,et al.  Mechanisms of inflammatory responses and development of insulin resistance: how are they interlinked? , 2016, Journal of Biomedical Science.

[12]  A. Andrei,et al.  Abdominal Obesity and Type 2 Diabetes Mellitus are Associated With Higher Seric Levels of IL 4 in Adults , 2016, Current health sciences journal.

[13]  M. Wabitsch,et al.  Importance of adipocyte cyclooxygenase‐2 and prostaglandin E2‐prostaglandin E receptor 3 signaling in the development of obesity‐induced adipose tissue inflammation and insulin resistance , 2016, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[14]  A. Mui,et al.  Hyporesponsiveness to the anti-inflammatory action of interleukin-10 in type 2 diabetes , 2016, Scientific Reports.

[15]  S. Mudaliar,et al.  Excessive secretion of IL-8 by skeletal muscle in type 2 diabetes impairs tube growth: potential role of PI3K and the Tie2 receptor. , 2015, American journal of physiology. Endocrinology and metabolism.

[16]  W. Jia,et al.  Thromboxane synthase deficiency improves insulin action and attenuates adipose tissue fibrosis. , 2015, American journal of physiology. Endocrinology and metabolism.

[17]  M. Laville,et al.  Insulin Resistance is Associated with MCP1-Mediated Macrophage Accumulation in Skeletal Muscle in Mice and Humans , 2014, PloS one.

[18]  J. Stenvang,et al.  Homogenous 96-Plex PEA Immunoassay Exhibiting High Sensitivity, Specificity, and Excellent Scalability , 2014, PloS one.

[19]  T. Imaizumi,et al.  Independent association of elevated serum hepatocyte growth factor levels with development of insulin resistance in a 10‐year prospective study , 2013, Clinical endocrinology.

[20]  Mingzhou Li,et al.  Gene expression profiling reveals distinct features of various porcine adipose tissues , 2013, Lipids in Health and Disease.

[21]  Ruiqiang Li,et al.  Co-methylated Genes in Different Adipose Depots of Pig are Associated with Metabolic, Inflammatory and Immune Processes , 2012, International journal of biological sciences.

[22]  D. Lamers,et al.  Identification and Validation of Novel Adipokines Released from Primary Human Adipocytes* , 2011, Molecular & Cellular Proteomics.

[23]  Albert Zlotnik,et al.  Homeostatic chemokine receptors and organ-specific metastasis , 2011, Nature Reviews Immunology.

[24]  S. Devaraj,et al.  Adipose tissue dysregulation in patients with metabolic syndrome. , 2011, The Journal of clinical endocrinology and metabolism.

[25]  F. Crea,et al.  Thromboxane production in morbidly obese subjects. , 2011, The American journal of cardiology.

[26]  R. Locksley,et al.  Eosinophils Sustain Adipose Alternatively Activated Macrophages Associated with Glucose Homeostasis , 2011, Science.

[27]  Simin Liu,et al.  Hepatocyte Growth Factor and Clinical Diabetes in Postmenopausal Women , 2010, Diabetes Care.

[28]  T. Mak,et al.  Lipocalin-2 Deficiency Attenuates Insulin Resistance Associated With Aging and Obesity , 2010, Diabetes.

[29]  S. Keller,et al.  12/15‐Lipoxygenase Products Induce Inflammation and Impair Insulin Signaling in 3T3‐L1 Adipocytes , 2009, Obesity.

[30]  F. Schick,et al.  Intermuscular adipose tissue (IMAT): Association with other adipose tissue compartments and insulin sensitivity , 2009, Journal of magnetic resonance imaging : JMRI.

[31]  R. Murphy,et al.  Transcellular biosynthesis of cysteinyl leukotrienes in vivo during mouse peritoneal inflammation , 2009, Proceedings of the National Academy of Sciences.

[32]  F. Crea,et al.  COX-1 sensitivity and thromboxane A2 production in type 1 and type 2 diabetic patients under chronic aspirin treatment. , 2009, European heart journal.

[33]  D. Greaves,et al.  Macrophage-derived human resistin exacerbates adipose tissue inflammation and insulin resistance in mice. , 2009, The Journal of clinical investigation.

[34]  Meng Chen,et al.  12-Lipoxygenase-knockout mice are resistant to inflammatory effects of obesity induced by Western diet. , 2008, American journal of physiology. Endocrinology and metabolism.

[35]  L. Kuller,et al.  Adipose tissue infiltration in skeletal muscle: age patterns and association with diabetes among men of African ancestry. , 2008, The American journal of clinical nutrition.

[36]  A. García-Ocaña,et al.  Hepatocyte Growth Factor Is a Novel Stimulator of Glucose Uptake and Metabolism in Skeletal Muscle Cells* , 2008, Journal of Biological Chemistry.

[37]  K. Campbell,et al.  TNF- (cid:1) acts via TNFR1 and muscle-derived oxidants to depress myofibrillar force in murine skeletal muscle , 2008 .

[38]  S. Weisberg,et al.  Obesity in C57BL/6J mice is characterized by adipose tissue hypoxia and cytotoxic T-cell infiltration , 2008, International Journal of Obesity.

[39]  R. O’Doherty,et al.  Inhibition or deletion of the lipopolysaccharide receptor Toll-like receptor-4 confers partial protection against lipid-induced insulin resistance in rodent skeletal muscle , 2008, Diabetologia.

[40]  G. Frühbeck,et al.  Proinflammatory Cytokines in Obesity: Impact of Type 2 Diabetes Mellitus and Gastric Bypass , 2007, Obesity surgery.

[41]  B. Pedersen,et al.  The biological roles of exercise-induced cytokines: IL-6, IL-8, and IL-15. , 2007, Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme.

[42]  R. Dantzer,et al.  Novel activity of an anti-inflammatory cytokine: IL-10 prevents TNFα-induced resistance to IGF-I in myoblasts , 2007, Journal of Neuroimmunology.

[43]  G. Freund,et al.  Type 2 Diabetes Impairs Insulin Receptor Substrate-2-Mediated Phosphatidylinositol 3-Kinase Activity in Primary Macrophages to Induce a State of Cytokine Resistance to IL-4 in Association with Overexpression of Suppressor of Cytokine Signaling-31 , 2007, The Journal of Immunology.

[44]  M. Stumvoll,et al.  Macrophage infiltration into omental versus subcutaneous fat across different populations: effect of regional adiposity and the comorbidities of obesity. , 2007, The Journal of clinical endocrinology and metabolism.

[45]  F. Liu,et al.  Prolonged exposure to resistin inhibits glucose uptake in rat skeletal muscles , 2007, Acta Pharmacologica Sinica.

[46]  M. Nalls,et al.  Reduced physical activity increases intermuscular adipose tissue in healthy young adults. , 2007, The American journal of clinical nutrition.

[47]  R. Considine,et al.  Adipose tissue production of hepatocyte growth factor contributes to elevated serum HGF in obesity. , 2006, American journal of physiology. Endocrinology and metabolism.

[48]  J. Eckel,et al.  Monocyte chemotactic protein-1 is a potential player in the negative cross-talk between adipose tissue and skeletal muscle. , 2006, Endocrinology.

[49]  R. Busse,et al.  Macrophages in human visceral adipose tissue: increased accumulation in obesity and a source of resistin and visfatin , 2006, Diabetologia.

[50]  R. Leibel,et al.  CCR2 modulates inflammatory and metabolic effects of high-fat feeding. , 2006, The Journal of clinical investigation.

[51]  Y. Halvorsen,et al.  Recombinant human FIZZ3/resistin stimulates lipolysis in cultured human adipocytes, mouse adipose explants, and normal mice. , 2005, Endocrinology.

[52]  Tamara B Harris,et al.  Obesity, regional body fat distribution, and the metabolic syndrome in older men and women. , 2005, Archives of internal medicine.

[53]  Tamara B Harris,et al.  Adipose tissue in muscle: a novel depot similar in size to visceral adipose tissue. , 2005, The American journal of clinical nutrition.

[54]  S. B. Pedersen,et al.  Monocyte chemoattractant protein-1 release is higher in visceral than subcutaneous human adipose tissue (AT): implication of macrophages resident in the AT. , 2005, The Journal of clinical endocrinology and metabolism.

[55]  J. Rokach,et al.  Biochemistry, biology and chemistry of the 5-lipoxygenase product 5-oxo-ETE. , 2005, Progress in lipid research.

[56]  R. Breyer,et al.  Pharmacology and signaling of prostaglandin receptors: multiple roles in inflammation and immune modulation. , 2004, Pharmacology & therapeutics.

[57]  S. Heymsfield,et al.  Intermuscular adipose tissue-free skeletal muscle mass: estimation by dual-energy X-ray absorptiometry in adults. , 2004, Journal of applied physiology.

[58]  S. Heymsfield,et al.  Sarcopenia and increased adipose tissue infiltration of muscle in elderly African American women. , 2004, The American journal of clinical nutrition.

[59]  A. Madan,et al.  Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. , 2004, Endocrinology.

[60]  M. Febbraio,et al.  Cytokine gene expression in human skeletal muscle during concentric contraction: evidence that IL-8, like IL-6, is influenced by glycogen availability. , 2004, American journal of physiology. Regulatory, integrative and comparative physiology.

[61]  D. Loskutoff,et al.  Monocyte chemoattractant protein 1 in obesity and insulin resistance , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[62]  R. Marfella,et al.  Association of low interleukin-10 levels with the metabolic syndrome in obese women. , 2003, The Journal of clinical endocrinology and metabolism.

[63]  S. Kritchevsky,et al.  Association between regional adipose tissue distribution and both type 2 diabetes and impaired glucose tolerance in elderly men and women. , 2003, Diabetes care.

[64]  K. Petersen,et al.  Assessment of skeletal muscle triglyceride content by (1)H nuclear magnetic resonance spectroscopy in lean and obese adolescents: relationships to insulin sensitivity, total body fat, and central adiposity. , 2002, Diabetes.

[65]  A. F. Stewart,et al.  Transgenic overexpression of hepatocyte growth factor in the beta-cell markedly improves islet function and islet transplant outcomes in mice. , 2001, Diabetes.

[66]  Z. Yablonka-Reuveni,et al.  Gene Expression Patterns of the Fibroblast Growth Factors and Their Receptors During Myogenesis of Rat Satellite Cells , 2000, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[67]  J. Ward,et al.  Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression. , 2000, Blood.

[68]  B. Goodpaster,et al.  Thigh adipose tissue distribution is associated with insulin resistance in obesity and in type 2 diabetes mellitus. , 2000, The American journal of clinical nutrition.

[69]  T. Nakamura,et al.  Hepatocyte growth factor plays a dual role in regulating skeletal muscle satellite cell proliferation and differentiation. , 1998, Biochimica et biophysica acta.

[70]  W Newman,et al.  Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils. , 1996, The Journal of clinical investigation.

[71]  R. Strieter,et al.  Interleukin-8 as a macrophage-derived mediator of angiogenesis. , 1992, Science.

[72]  塚川 絵理.  Independent association of elevated serum hepatocyte growth factor levels with development of insulin resistance in a 10-year prospective study , 2013 .

[73]  J. Steinacker,et al.  Skeletal muscle IL-4, IL-4Ralpha, IL-13 and IL-13Ralpha1 expression and response to strength training. , 2007, Exercise immunology review.

[74]  R. Palanivel,et al.  Regulation of insulin signalling, glucose uptake and metabolism in rat skeletal muscle cells upon prolonged exposure to resistin , 2005, Diabetologia.

[75]  A. Matsukawa,et al.  Functional Distinction between CXC Chemokines, Interleukin-8 (IL-8), and Growth Related Oncogene (GRO)α in Neutrophil Infiltration , 2002, Laboratory Investigation.

[76]  B. Wierusz-Wysocka,et al.  Serum interleukin-8 level is increased in diabetic patients , 1999, Diabetologia.